ADA 2017: Site of absorption of an oral formulation of semaglutide

Absorption of oral peptide-based drug formulations is challenged by the fact that peptides are degraded in the stomach due to low pH and proteolytic enzymes, as well as by their limited permeability across the gastrointestinal epithelium.

Download our scientific poster entitled, 'Site of absorption of an oral formulation of semaglutide' from ADA 2017.